Sat.Aug 22, 2020 - Fri.Aug 28, 2020

article thumbnail

No digitization with HCP’s is not permanent

World of DTC Marketing

IN SUMMARY : When patients return to doctor’s offices will HCP’s have time to go online with every drug company that requests an online detail? Will patients be happy with telehealth once they feel it’s safe to return to physicians’ offices? After I read the Medscape report on the move to digitization I decided to reach out to some industry contacts to hear what they had to say.

article thumbnail

Episode 21 Part 3 of 3 – Virtual Trade Shows and Alternatives – What the Doctors Say

Medical Device Success

Reading time: 2 – 2 minutes What do doctors think of this virtual world of events and contacts? In this podcast and video cast, Lisa Bichsel, Lauren Dustman and I interview a multi-specialty panel of 5 doctors to hear what they have to say. We talk to an ophthalmologist, a radiologist, an emergency medicine physician, a gastroenterologist and a family practitioner.

Doctors 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Adapting Customer Engagement Strategies to the COVID Landscape

Pharma Marketing Network

The pharmaceutical industry has been under pressure for the past decade to change its go-to-market models. While the industry has attempted change, any change to its approach has been guarded. But the industry’s new challenge—marketing and selling in a COVID-19 environment—abruptly changes the customer interaction landscape, perhaps permanently. In office/in person sales promotion, the staple of pharmaceutical company activities, is simply not possible today with interactions reduced to the spor

article thumbnail

Three Steps to Hitting Your MLR Targets in 2021 

Clarify Health

While many plans did not meet their minimum medical loss ratio (or MLR Target) for 2020, in three steps, payers can better position themselves to meet these targets in 2021. But first… What is a Medical Loss Ratio (MLR)? The medical loss ratio (MLR), also known as the medical cost ratio (MCR), is the percentage of member premiums that health insurers spend on medical care or quality improvement activities for their patient population.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Medscape on shift to digital

World of DTC Marketing

COVID-19 has disrupted traditional healthcare person-to-person communication and accelerated digital options, such as telehealth and remote patient-clinician contacts, digital therapeutics that deliver remote patient monitoring, and interventions through the use of software. But is this really the future? Medscape conducted some research in May to find out.

Doctors 213
article thumbnail

The Most Promising COVID-19 Vaccines in Development

Source Explorer

[link].

52

More Trending

article thumbnail

The most dangerous Tweet

World of DTC Marketing

QUICK READ: Today Trump suggested that the FDA is part of a “deep state” conspiracy to delay a COVID-19 vaccine until after the election. This is beyond irresponsible and clearly shows that he is unfit mentally to hold office. “The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics,” the president wrote.

article thumbnail

The pharma company of the future

World of DTC Marketing

Everyone, it seems, has issues with big pharma. From obscene profits to outrageous compensation for CEOs pharma has seems to have the attitude of a big corporation who doesn’t care. The question that everyone seems to be avoiding is “can pharma serve both Wall Street and patients?” Pharma continues to donate a lot of money to the Republican Party and in particular Mitch McConnell.

Pharma 144
article thumbnail

Sorry.COVID treatment data may not be reliable

World of DTC Marketing

IN SUMMARY: “For the first time ever, I feel like official people in communications and people at the F.D.A. grossly misrepresented data about a therapy,” said Dr. Walid Gellad, who leads the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. That should tell you all you need to know about how bad things are with the FDA and trust in drug approvals.

article thumbnail

This is an emergency!

World of DTC Marketing

When trust in the FDA declines our whole population is at risk. Ignorance should never be replaced by politics and it’s up to every drug company CEO, health insurer, PBM, and physician to make it known that politics will ver, ever, play a role in drug approvals. In my twenty-plus years in healthcare I thought I had seen it all but what I read this weekend was beyond disturbing.

Insurance 144
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.